Lin J, Gallenito M, Hattne J, Gonen T
bioRxiv. 2025; .
PMID: 40027750
PMC: 11870483.
DOI: 10.1101/2025.02.18.638921.
Werner A, Krapoth N, Norris M, Heine A, Klebe G, Saphire E
ACS Omega. 2024; 9(30):33193-33203.
PMID: 39100314
PMC: 11292656.
DOI: 10.1021/acsomega.4c04829.
Dunge A, Phan C, Uwangue O, Bjelcic M, Gunnarsson J, Wehlander G
IUCrJ. 2024; 11(Pt 5):831-842.
PMID: 39072424
PMC: 11364032.
DOI: 10.1107/S2052252524006134.
Metz A, Stegmann D, Panepucci E, Buehlmann S, Huang C, McAuley K
Acta Crystallogr D Struct Biol. 2024; 80(Pt 5):328-335.
PMID: 38606665
PMC: 11066879.
DOI: 10.1107/S2059798324002833.
Fusser F, Wollenhaupt J, Weiss M, Kummel D, Koch O
Acta Crystallogr D Struct Biol. 2023; 79(Pt 9):857-865.
PMID: 37574972
PMC: 10478635.
DOI: 10.1107/S2059798323005223.
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer.
Lu Y, Yang Y, Zhu G, Zeng H, Fan Y, Guo F
Int J Biol Sci. 2023; 19(11):3360-3382.
PMID: 37496997
PMC: 10367563.
DOI: 10.7150/ijbs.83026.
EIGER2 hybrid-photon-counting X-ray detectors for advanced synchrotron diffraction experiments.
Donath T, Sisak Jung D, Burian M, Radicci V, Zambon P, Fitch A
J Synchrotron Radiat. 2023; 30(Pt 4):723-738.
PMID: 37343017
PMC: 10325006.
DOI: 10.1107/S160057752300454X.
Crystal polymorphism in fragment-based lead discovery of ligands of the catalytic domain of UGGT, the glycoprotein folding quality control checkpoint.
Caputo A, Ibba R, Le Cornu J, Darlot B, Hensen M, Lipp C
Front Mol Biosci. 2023; 9:960248.
PMID: 36589243
PMC: 9794592.
DOI: 10.3389/fmolb.2022.960248.
Of problems and opportunities-How to treat and how to not treat crystallographic fragment screening data.
Weiss M, Wollenhaupt J, Correy G, Fraser J, Heine A, Klebe G
Protein Sci. 2022; 31(9):e4391.
PMID: 36040268
PMC: 9424839.
DOI: 10.1002/pro.4391.
Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitors.
Osipov E, Munawar A, Beelen S, Fearon D, Douangamath A, Wild C
RSC Chem Biol. 2022; 3(8):1013-1027.
PMID: 35974998
PMC: 9347357.
DOI: 10.1039/d2cb00052k.
Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity.
Tsika A, Gallo A, Fourkiotis N, Argyriou A, Sreeramulu S, Lohr F
J Mol Biol. 2022; 434(16):167720.
PMID: 35839840
PMC: 9284540.
DOI: 10.1016/j.jmb.2022.167720.
Experiences From Developing Software for Large X-Ray Crystallography-Driven Protein-Ligand Studies.
Pearce N, Skyner R, Krojer T
Front Mol Biosci. 2022; 9:861491.
PMID: 35480897
PMC: 9035521.
DOI: 10.3389/fmolb.2022.861491.
SAMPL7 protein-ligand challenge: A community-wide evaluation of computational methods against fragment screening and pose-prediction.
Grosjean H, Isik M, Aimon A, Mobley D, Chodera J, von Delft F
J Comput Aided Mol Des. 2022; 36(4):291-311.
PMID: 35426591
PMC: 9010448.
DOI: 10.1007/s10822-022-00452-7.
Fast fragment- and compound-screening pipeline at the Swiss Light Source.
Kaminski J, Vera L, Stegmann D, Vering J, Eris D, Smith K
Acta Crystallogr D Struct Biol. 2022; 78(Pt 3):328-336.
PMID: 35234147
PMC: 8900825.
DOI: 10.1107/S2059798322000705.
Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.
Metz A, Wollenhaupt J, Glockner S, Messini N, Huber S, Barthel T
Acta Crystallogr D Struct Biol. 2021; 77(Pt 9):1168-1182.
PMID: 34473087
PMC: 8411975.
DOI: 10.1107/S2059798321008196.
FragMAXapp: crystallographic fragment-screening data-analysis and project-management system.
Lima G, Jagudin E, Talibov V, Benz L, Marullo C, Barthel T
Acta Crystallogr D Struct Biol. 2021; 77(Pt 6):799-808.
PMID: 34076593
PMC: 8171072.
DOI: 10.1107/S2059798321003818.
Facilitated crystal handling using a simple device for evaporation reduction in microtiter plates.
Barthel T, Huschmann F, Wallacher D, Feiler C, Klebe G, Weiss M
J Appl Crystallogr. 2021; 54(Pt 1):376-382.
PMID: 33833659
PMC: 7941301.
DOI: 10.1107/S1600576720016477.
Systematic Assessment of Fragment Identification for Multitarget Drug Design.
Brunst S, Kramer J, Kilu W, Heering J, Pollinger J, Hiesinger K
ChemMedChem. 2020; 16(7):1088-1092.
PMID: 33283450
PMC: 8049054.
DOI: 10.1002/cmdc.202000858.
Discovery of allosteric binding sites by crystallographic fragment screening.
Krojer T, Fraser J, von Delft F
Curr Opin Struct Biol. 2020; 65:209-216.
PMID: 33171388
PMC: 10979522.
DOI: 10.1016/j.sbi.2020.08.004.
Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis.
Ginn H
Acta Crystallogr D Struct Biol. 2020; 76(Pt 11):1134-1144.
PMID: 33135684
PMC: 7604910.
DOI: 10.1107/S2059798320012619.